Immunotherapy for Pediatric Leukemia

por Shah, Nirali N., Dave, Hema, Wayne, Alan S.
Publicado 2013

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia

por Raskin, Scott, Van Pelt, Stacey, Toner, Keri, Balakrishnan, Preethi Bala, Dave, Hema, Bollard, Catherine M., Yvon, Eric
Publicado 2021

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodie...

por Dave, Hema, Anver, Miriam R., Butcher, Donna O., Brown, Patrick, Khan, Javed, Wayne, Alan S., Baskar, Sivasubramanian, Rader, Christoph
Publicado 2012

Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood

por Dave, Hema, Luo, Min, Blaney, J.W., Patel, Shabnum, Barese, Cecilia, Cruz, Conrad Russell, Shpall, Elizabeth J., Bollard, Catherine M., Hanley, Patrick J.
Publicado 2017

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma

por Castellino, Sharon M., Pei, Qinglin, Parsons, Susan K., Hodgson, David, Mccarten, Kathleen, Horton, Terzah, Cho, Steve, Wu, Yue, Punnett, Angela, Dave, Hema, Henderson, Tara O., Hoppe, Bradford S., Charpentier, Ann-Marie, Keller, Frank G., Kelly, Kara M.
Publicado 2022

Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

por Dave, Hema, Terpilowski, Madeline, Mai, Mimi, Toner, Keri, Grant, Melanie, Stanojevic, Maja, Lazarski, Christopher, Shibli, Abeer, Bien, Stephanie A., Maglo, Philip, Hoq, Fahmida, Schore, Reuven, Glenn, Martha, Hu, Boyu, Hanley, Patrick J., Ambinder, Richard, Bollard, Catherine M.
Publicado 2022

SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report

por McNerney, Kevin Owen, Richards, Rebecca M, Aguayo-Hiraldo, Paibel, Calkoen, Friso G, Talano, Julie-An, Moskop, Amy, Balduzzi, Adriana, Krajewski, Jennifer, Dave, Hema, Vatsayan, Anant, Callahan, Colleen, Liu, Hongyan, Li, Yimei, Davis, Kara Lynn, Maude, Shannon L
Publicado 2023

Case Report: Fatal Complications of BK Virus-Hemorrhagic Cystitis and Severe Cytokine Release Syndrome Following BK Virus-Specific T-Cells

por Holland, Elizabeth M., Gonzalez, Corina, Levy, Elliot, Valera, Vladimir A., Chalfin, Heather, Klicka-Skeels, Jacquelyn, Yates, Bonnie, Kleiner, David E., Hadigan, Colleen, Dave, Hema, Shalabi, Haneen, Hickstein, Dennis D., Su, Helen C., Grimley, Michael, Freeman, Alexandra F., Shah, Nirali N.
Publicado 2021

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

por Forlenza, Christopher J., Rosenzweig, Jaclyn, Mauguen, Audrey, Buhtoiarov, Ilia, Cuglievan, Branko, Dave, Hema, Deyell, Rebecca J., Flerlage, Jamie E., Franklin, Anna K., Krajewski, Jennifer, Leger, Kasey J., Marks, Lianna J., Norris, Robin E., Pacheco, Martha, Willen, Faye, Yan, Adam Paul, Harker-Murray, Paul D., Giulino-Roth, Lisa
Publicado 2023

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

por Kinoshita, Hannah, Cooke, Kenneth R., Grant, Melanie, Stanojevic, Maja, Cruz, C. Russell, Keller, Michael, Fortiz, Maria Fernanda, Hoq, Fahmida, Lang, Haili, Barrett, A. John, Liang, Hua, Tanna, Jay, Zhang, Nan, Shibli, Abeer, Datar, Anushree, Fulton, Kenneth, Kukadiya, Divyesh, Zhang, Anqing, Williams, Kirsten M., Dave, Hema, Dome, Jeffrey S., Jacobsohn, David, Hanley, Patrick J., Jones, Richard J., Bollard, Catherine M.
Publicado 2022